Literature DB >> 27502741

The contribution of the citrate pathway to oxidative stress in Down syndrome.

Paolo Convertini1, Alessio Menga2, Generoso Andria3, Iris Scala3, Anna Santarsiero1, Maria A Castiglione Morelli1, Vito Iacobazzi4, Vittoria Infantino5.   

Abstract

Inflammatory conditions and oxidative stress have a crucial role in Down syndrome (DS). Emerging studies have also reported an altered lipid profile in the early stages of DS. Our previous works demonstrate that citrate pathway activation is required for oxygen radical production during inflammation. Here, we find up-regulation of the citrate pathway and down-regulation of carnitine/acylcarnitine carrier and carnitine palmitoyl-transferase 1 genes in cells from children with DS. Interestingly, when the citrate pathway is inhibited, we observe a reduction in oxygen radicals as well as in lipid peroxidation levels. Our preliminary findings provide evidence for a citrate pathway dysregulation, which could be related to some phenotypic traits of people with DS.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  ATP citrate lyase; Down syndrome; citrate pathway; inflammation; mitochondrial citrate carrier; oxidative stress

Mesh:

Substances:

Year:  2016        PMID: 27502741      PMCID: PMC5095497          DOI: 10.1111/imm.12659

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

1.  Role of FOXA and Sp1 in mitochondrial acylcarnitine carrier gene expression in different cell lines.

Authors:  Paolo Convertini; Vittoria Infantino; Faustino Bisaccia; Ferdinando Palmieri; Vito Iacobazzi
Journal:  Biochem Biophys Res Commun       Date:  2010-12-03       Impact factor: 3.575

2.  The lipogenesis pathway as a cancer target.

Authors:  Hanley N Abramson
Journal:  J Med Chem       Date:  2011-08-03       Impact factor: 7.446

3.  Predictors of BMI among adults with Down syndrome: the social context of health promotion.

Authors:  G T Fujiura; N Fitzsimons; B Marks; B Chicoine
Journal:  Res Dev Disabil       Date:  1997 Jul-Aug

4.  Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan.

Authors:  P L Bruynzeel; P T Kok; M L Hamelink; A M Kijne; J Verhagen
Journal:  FEBS Lett       Date:  1985-09-23       Impact factor: 4.124

5.  ATP-citrate lyase is essential for macrophage inflammatory response.

Authors:  Vittoria Infantino; Vito Iacobazzi; Ferdinando Palmieri; Alessio Menga
Journal:  Biochem Biophys Res Commun       Date:  2013-09-17       Impact factor: 3.575

6.  Statins, fibrates and retinoic acid upregulate mitochondrial acylcarnitine carrier gene expression.

Authors:  Vito Iacobazzi; Paolo Convertini; Vittoria Infantino; Pasquale Scarcia; Simona Todisco; Ferdinando Palmieri
Journal:  Biochem Biophys Res Commun       Date:  2009-08-06       Impact factor: 3.575

7.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

8.  Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.

Authors:  W S Griffin; L C Stanley; C Ling; L White; V MacLeod; L J Perrot; C L White; C Araoz
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Lipid profiles of children with Down syndrome compared with their siblings.

Authors:  Tahira Adelekan; Sheela Magge; Justine Shults; Virginia Stallings; Nicolas Stettler
Journal:  Pediatrics       Date:  2012-05-14       Impact factor: 7.124

10.  Epigallocatechin-3-gallate prevents oxidative phosphorylation deficit and promotes mitochondrial biogenesis in human cells from subjects with Down's syndrome.

Authors:  Daniela Valenti; Domenico De Rasmo; Anna Signorile; Leonardo Rossi; Lidia de Bari; Iris Scala; Barbara Granese; Sergio Papa; Rosa Anna Vacca
Journal:  Biochim Biophys Acta       Date:  2013-01-02
View more
  14 in total

1.  Heritability and genetic variance of dementia with Lewy bodies.

Authors:  Rita Guerreiro; Valentina Escott-Price; Dena G Hernandez; Celia Kun-Rodrigues; Owen A Ross; Tatiana Orme; Joao Luis Neto; Susana Carmona; Nadia Dehghani; John D Eicher; Claire Shepherd; Laura Parkkinen; Lee Darwent; Michael G Heckman; Sonja W Scholz; Juan C Troncoso; Olga Pletnikova; Ted Dawson; Liana Rosenthal; Olaf Ansorge; Jordi Clarimon; Alberto Lleo; Estrella Morenas-Rodriguez; Lorraine Clark; Lawrence S Honig; Karen Marder; Afina Lemstra; Ekaterina Rogaeva; Peter St George-Hyslop; Elisabet Londos; Henrik Zetterberg; Imelda Barber; Anne Braae; Kristelle Brown; Kevin Morgan; Claire Troakes; Safa Al-Sarraj; Tammaryn Lashley; Janice Holton; Yaroslau Compta; Vivianna Van Deerlin; Geidy E Serrano; Thomas G Beach; Suzanne Lesage; Douglas Galasko; Eliezer Masliah; Isabel Santana; Pau Pastor; Monica Diez-Fairen; Miquel Aguilar; Pentti J Tienari; Liisa Myllykangas; Minna Oinas; Tamas Revesz; Andrew Lees; Brad F Boeve; Ronald C Petersen; Tanis J Ferman; Neill Graff-Radford; Nigel J Cairns; John C Morris; Stuart Pickering-Brown; David Mann; Glenda M Halliday; John Hardy; John Q Trojanowski; Dennis W Dickson; Andrew Singleton; David J Stone; Jose Bras
Journal:  Neurobiol Dis       Date:  2019-04-03       Impact factor: 5.996

2.  Plasma and urinary metabolomic profiles of Down syndrome correlate with alteration of mitochondrial metabolism.

Authors:  Maria Caracausi; Veronica Ghini; Chiara Locatelli; Martina Mericio; Allison Piovesan; Francesca Antonaros; Maria Chiara Pelleri; Lorenza Vitale; Rosa Anna Vacca; Federica Bedetti; Maria Chiara Mimmi; Claudio Luchinat; Paola Turano; Pierluigi Strippoli; Guido Cocchi
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

Review 3.  Lipid metabolism reprogramming and its potential targets in cancer.

Authors:  Chunming Cheng; Feng Geng; Xiang Cheng; Deliang Guo
Journal:  Cancer Commun (Lond)       Date:  2018-05-21

Review 4.  Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets.

Authors:  Antonella Izzo; Nunzia Mollo; Maria Nitti; Simona Paladino; Gaetano Calì; Rita Genesio; Ferdinando Bonfiglio; Rita Cicatiello; Maria Barbato; Viviana Sarnataro; Anna Conti; Lucio Nitsch
Journal:  Mol Med       Date:  2018-03-15       Impact factor: 6.354

5.  New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.

Authors:  Anna Santarsiero; Pietro Leccese; Paolo Convertini; Angela Padula; Paolo Abriola; Salvatore D'Angelo; Faustino Bisaccia; Vittoria Infantino
Journal:  Mediators Inflamm       Date:  2018-06-28       Impact factor: 4.711

6.  Evaluation of oxidative stress and the microenvironment in oral submucous fibrosis.

Authors:  Vertika Rai; Surajit Bose; Satadal Saha; Chandan Chakraborty
Journal:  Heliyon       Date:  2019-04-12

7.  Phenolic Compounds of Red Wine Aglianico del Vulture Modulate the Functional Activity of Macrophages via Inhibition of NF-κB and the Citrate Pathway.

Authors:  Anna Santarsiero; Paolo Convertini; Antonio Vassallo; Valentina Santoro; Simona Todisco; Dominga Iacobazzi; Yvonne Fondufe-Mittendorf; Giuseppe Martelli; Marcos R de Oliveira; Rosangela Montanaro; Vincenzo Brancaleone; Johannes Stöckl; Vittoria Infantino
Journal:  Oxid Med Cell Longev       Date:  2021-05-25       Impact factor: 6.543

Review 8.  Citrate usage in the leading causes of blindness: new possibilities for the old metabolite.

Authors:  Marta Michalczuk; Beata Urban; Tadeusz Porowski; Anna Wasilewska; Alina Bakunowicz-Łazarczyk
Journal:  Metabolomics       Date:  2018-06-05       Impact factor: 4.290

Review 9.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

10.  RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome.

Authors:  Eric D Hamlett; Erik Hjorth; Aurélie Ledreux; Anah Gilmore; Marianne Schultzberg; Ann Charlotte Granholm
Journal:  Glia       Date:  2020-01-16       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.